Marine Natural Products Lab

Kerr Research Group
Home / Kerr Research Group / Lab Members / Martin Lanteigne

Martin Lanteigne

Research Interests:

Planning, running, troubleshooting and quality control for a panel of different types of whole cell-based assays including bacterial and fungal (bio-safety level 1 and 2 human pathogen (10-15 organisms)). 

-Screening our extract library for antimicrobial compound. After completion of the assays, the results are calculated, analyzed and distributed to recipients followed by archival of the data in a digital laboratory repository.

Developing new high-throughput assays for screening purposes.  

-Working on a project that needs a high-throughput assay to screen for Y enzymes for X number of organisms in Z amount of time.

-As well as work on a biofilm disruption assay for the screening of compounds that could disrupt the formation or already formed biofilms. 

BSc in Biochemistry
University of Moncton, Moncton, NB (2004-2007)
2- year diploma in biotechnology
CCNB (New Brunswick Community College) Edmunston, NB (2002-2004)
Work Experience:
Microbiologist research assistant in the Kerr Lab, Charlottetown, PE (2009-present)
Bio-molecular research assistant, University of Prince Edward, PE (2007 - 2009)
Co-op training,  ACRI (Atlantic Cancer Research Institute) Moncton, NB (summer 2004 - summer 2005)

1. E.Marchal, Md. I. Uddin, D. A. Smithen, C. L. A. Hawco, M. Lanteigne, D. P. Overy, R. G. Kerr and A. Thompson. Antimicrobial activity of non-natural prodigiosenes. RSC Advances 2013, 3, 22967–22971

2. David P. Overy, Fabrice Berrue, Hebelin Correa, Novriyandi Hanif, Kathryn Hay, Martin Lanteigne, Kathrine Mquiliana, Stephanie Duffy, Patricia Boland, Ramesh Jagannathan, Gavin S. Carr, Marieke Vansteeland and Russell G. Kerr*.Sea foam as a source of fungal inoculum for the isolation of biologically active natural products. Mycology, 2014.

Maritime natural product conference: Antimicrobial screening of a library of extracts from marine invertebrates
Seminar: Anti-Cancer treatment Targeting BCL-2 family using SiRNA